CLINICAL_TRIALS
trial_result
· 2014-11-13
Clinical Trial Update: Safety and Tolerability of Oxycyte in Patients With Traumatic Brain Injury (TBI) [Phase 2]
Summary
The Phase 2 trial evaluating the safety and tolerability of Oxycyte in patients with traumatic brain injury has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Tenax Therapeutics, Inc. | Conditions: Traumatic Brain Injury | Phase 2 | Status: TERMINATED